NCT06706856 Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
| NCT ID | NCT06706856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Diego |
| Condition | MASLD |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-09-23 |
| Primary Completion | 2029-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-09-23 with a primary completion date of 2029-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study is being conducted to find out more about advanced ultrasound techniques to non-invasively evaluate liver disease in children. The investigators are developing advanced techniques for analyzing ultrasound data and images of the liver, and they will compare it to other established methods used to evaluate the liver, including liver MRI. The investigators plan to develop and test the advanced analysis techniques using conventional full-size ultrasound machines and, if possible, small handheld devices. Our goals are: * To assess the accuracy of the advanced ultrasound analysis techniques in children * To implement and assess these advanced technique on small handheld ultrasound devices, if possible
Eligibility Criteria
Inclusion Criteria: * Age 9 to 18 years * Presence of risk factors for having MASLD * Ability and willingness of participant or legal guardian/parent to give written informed consent * Participant is willing to give written assent * Able and willing to undergo all study procedures Exclusion Criteria: * Known liver disease other than MASLD * Pregnant or trying to become pregnant * Inability to undergo an MR study: weight exceeding scanner table limit, waist circumference \> 140 cm, claustrophobie, and/or metal implants.
Contact & Investigator
Jeffrey B Schwimmer, MD
PRINCIPAL INVESTIGATOR
University of California, San Diego
Frequently Asked Questions
Who can join the NCT06706856 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 18 Years, studying MASLD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06706856 currently recruiting?
Yes, NCT06706856 is actively recruiting participants. Contact the research team at amalba@health.ucsd.edu for enrollment information.
Where is the NCT06706856 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT06706856 clinical trial?
NCT06706856 is sponsored by University of California, San Diego. The principal investigator is Jeffrey B Schwimmer, MD at University of California, San Diego. The trial plans to enroll 120 participants.